SCHEMBL7815599

SCHEMBL7815599

COC(OC(=O)Cl)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
CYP2D6 P10635 2/20 0.43
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
CYP3A4 P08684 2/20 0.40
MEN1 O00255 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
SRC P12931 1/20 0.39
PKM P14618 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
HTR1A P08908 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL986067 0.84 KMT2A (0.48) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL286685 0.84 KMT2A (0.48) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL6372424 0.83 ALDH1A1 (0.54) KMT2ACYP2D6ALDH1A1CYP3A4TSHR
SCHEMBL6176608 0.82 KMT2A (0.47) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL10827238 0.82 KMT2A (0.47) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL1030015 0.82 ALDH1A1 (0.53) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL11386291 0.81 KMT2A (0.47) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL113808 0.81 CYP2D6 (0.46) KMT2ACYP2D6ALDH1A1LMNACYP3A4
SCHEMBL28881766 0.79 ALDH1A1 (0.50) KMT2ACYP2D6ALDH1A1CYP3A4TSHR
SCHEMBL6372481 0.79 KMT2A (0.41) KMT2ACYP2D6ALDH1A1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1092649-C Thiazolidinone compound or angina pectoris therapeutic or prophylactic agent containing the same as active ingredient SANKYO CO (JP) 2002-10-16 CN disclosed
EP-0798298-B1 THIAZOLIDINONE OR OXAZOLIDINONE DERIVATIVES TO TREAT ANGINA PECTORIS OR COMPOSITIONS CONTAINING THE SAME AS ACTIVE INGREDIENT SANKYO CO (JP) 2001-08-08 EP disclosed
US-5843973-A Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
CN-1175250-A Thiazolidinone compound or angina pectoris therapeutic or prophylactic agent containing the same as active ingredient SANKYO CO (JP) 1998-03-04 CN disclosed
EP-0798298-A1 THIAZOLIDINONE COMPOUNDS OR ANGINA PECTORIS REMEDY OR PREVENTIVE CONTAINING THE SAME AS ACTIVE INGREDIENT SANKYO COMPANY LIMITED (JP) 1997-10-01 EP disclosed
EP-0346756-A1 Process for production of sulfonium compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1989-12-20 EP disclosed